European Archives - Page 28 of 1235 - European Medical Journal

Portable Blood Test Detects Infections in 15 Minutes with High Accuracy

Portable $2 test detects deadly infections from a drop of blood within 15 minutes, with unmatched sensitivity.

Measuring Quality of Life in Hidradenitis Suppurativa Patients

This study evaluated the psychometric performance and interpretability of HiSQOL using data from two multinational Phase III trials of bimekizumab in moderate-to-severe HS.

Semaglutide Lowers Cardiovascular Risks But Raises Health Care Costs

Semaglutide improves cardiovascular risk factors but raises health care costs, finds large multicentre cohort study.

Overactive Bladder Predicts Hypotension Risk After Spinal Anaesthesia

The authors hypothesised that, in women with OAB, the additional sympathetic blockade produced by spinal anaessthesia would further unmask parasympathetic dominance.

AI Designs New Antibiotics to Tackle Drug-Resistant Bacteria

An AI-driven drug discovery platform has created new antibiotics with unique mechanisms against drug-resistant N. gonorrhoeae and MRSA, showing success in preclinical models.

Men with Dementia Face Higher Mortality and Hospitalisation Rates Than Women

Men with dementia show higher mortality and hospitalisation rates than women, according to major US Medicare study.

Maternal Allergy Linked to Reduced Breast Milk Oligosaccharides

In a prospective study measuring the 14 most abundant HMOs in colostrum and at three months postpartum, researchers tested whether maternal supplementation with ω-3 polyunsaturated fatty acids alters HMO profiles.

Five-Minute Antibody Test Could Transform Hepatitis C Screening

Discover a study assessing whether a five-minute rapid antibody test can speed up hepatitis C diagnosis. Read on.

Emanuele Angelucci, Director of Hematology and Cellular Therapies and Director of the Stem Cell Transplant.

Hema Now: Episode 23: New Frontiers in Treating Haemoglobinopathies

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

Study Explores Real-World Rituximab Use in Rheumatoid Arthritis

In a long-term real-world study, researchers found that flare-based rituximab retreatment for rheumatoid arthritis maintained high drug retention but led to cycles of fluctuating disease activity and wellbeing.